Gadodiamide-based coronary angiography in a patient with severe renal insufficiency.
The risk of contrast-induced nephropathy (CIN) is extremely high in patients with preexisting renal insufficiency. Gadolinium-based coronary angiography has been proposed as an approach to prevent CIN in this high risk subgroup. We report the use of gadodiamide-based coronary angiography in a patient with severe renal insufficiency and in vitro comparisons of combinations of iodinated contrast with gadodiamide and saline.
Gupta
Rajiv
R
From the University of Texas Medical Branch, Galveston, Texas 77555, USA.
Uretsky
Barry F
BF
D003287:Contrast Media / Q000008:administration & dosage*; D017023:Coronary Angiography; D019786:Gadolinium DTPA; D006801:Humans; D007668:Kidney / Q000000981:diagnostic imaging / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D051437:Renal Insufficiency / Q000000981:diagnostic imaging*; D012720:Severity of Illness Index; D014283:Triiodobenzoic Acids
D003287:Contrast Media; D014283:Triiodobenzoic Acids; C064925:gadodiamide; C044834:iodixanol; D019786:Gadolinium DTPA